Lina Ghibelli

Professor of Applied Biology

Department of Biology
Laboratory of Applied Biology
Tel. 06-7259-4323
e-mail  ghibelli@uniroma2.it

 

 

 

 

 

 

 

 

Latest publications

  • 2020 – Discovering the hidden messages within cell trajectories using a deep learning approach for in vitro evaluation of cancer drug treatments – Scientific Reports10.1038/s41598-020-64246-3
  • 2020 – Editorial: Tumor Systems Biology: How to Therapeutically Redirect Dysregulated Homeostasis in Tumor Systems (i.e., Anakoinosis) – Frontiers in Oncology10.3389/fonc.2020.01675
  • 2020 – Polylactic is a Sustainable, Low Absorption, Low Autofluorescence Alternative to Other Plastics for Microfluidic and Organ-on-Chip Applications – Analytical Chemistry10.1021/acs.analchem.0c00651
  • 2020 – A camera sensors-based system to study drug effects on in vitro motility: The case of PC-3 prostate cancer cells – Sensors (Switzerland)10.3390/s20051531
  • 2019 – Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue—Going Beyond Apoptosis Induction – Frontiers in Oncology10.3389/fonc.2019.01408
  • 2019 – Learning Cancer-Related Drug Efficacy Exploiting Consensus in Coordinated Motility within Cell Clusters – IEEE Transactions on Biomedical Engineering10.1109/TBME.2019.2897825
  • 2019 – A computational model of tumor growth and anakoinosis – Frontiers in Pharmacology10.3389/fphar.2019.00287
  • 2018 – Clinical efficacy of a novel therapeutic principle, anakoinosis – Frontiers in Pharmacology10.3389/fphar.2018.01357
  • 2018 – Lowering etoposide doses shifts cell demise from caspase-dependent to differentiation and caspase-3-independent apoptosis via DNA damage response, inducing AML culture extinction – Frontiers in Pharmacology10.3389/fphar.2018.01307
  • 2018 – Peroxisome proliferator-activated receptors (PPAR)γ agonists as master modulators of tumor tissue – International Journal of Molecular Sciences10.3390/ijms19113540
  • 2018 – Cerium oxide nanoparticles reestablish cell integrity checkpoints and apoptosis competence in irradiated HaCaT cells via novel redox-independent activity – Frontiers in Pharmacology10.3389/fphar.2018.01183
  • 2018 – Not only redox: The multifaceted activity of cerium oxide nanoparticles in cancer prevention and therapy – Frontiers in Oncology10.3389/fonc.2018.00309
  • 2018 – Uncertainty evaluation of a VBM system for AFM study of cell-cerium oxide nanoparticles interactions – IEEE Transactions on Instrumentation and Measurement10.1109/TIM.2018.2799118
  • 2018 – Biomodulatory treatment with azacitidine, all-trans retinoic acid and pioglitazone induces differentiation of primary AML blasts into neutrophil like cells capable of ROS production and phagocytosis – Frontiers in Pharmacology10.3389/fphar.2018.01380
  • 2017 – A novel synthetic approach of cerium oxide nanoparticles with improved biomedical activity – Scientific Reports10.1038/s41598-017-04098-6
  • 2017 – Cerium oxide nanoparticles inhibit differentiation of neural stem cells – Scientific Reports10.1038/s41598-017-09430-8
  • 2017 – Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial – Medical Oncology10.1007/s12032-017-1040-0
  • 2017 – Slow release of etoposide from dextran conjugation shifts etoposide activity from cytotoxicity to differentiation: A promising tool for dosage control in anticancer metronomic therapy – Nanomedicine: Nanotechnology, Biology, and Medicine10.1016/j.nano.2017.05.004
  • 2017 – AFM-based robust image analysis to contrast reversal effects in cell-cerium oxide nanoparticles interactions – I2MT 2017 – 2017 IEEE International Instrumentation and Measurement Technology Conference, Proceedings10.1109/I2MTC.2017.7969970